Assuming that the Aβ excess induces TNFSF10 expression in neurons [13], we suggest that neutralization of TNFSF10 represents a potential strategy to limit Aβ production, with consistent subsequent improvement of the cognitive outcome in AD [19]. Here, TNFSF10 is linked to Alzheimer disease.